SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

AdaptHealth Corp. – ‘S-3’ on 6/28/21 – ‘EX-5.1’

On:  Monday, 6/28/21, at 9:02pm ET   ·   As of:  6/29/21   ·   Accession #:  1104659-21-86386   ·   File #:  333-257493

Previous ‘S-3’:  ‘S-3’ on 12/18/20   ·   Latest ‘S-3’:  This Filing   ·   22 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/29/21  AdaptHealth Corp.                 S-3                    5:327K                                   Toppan Merrill/FA

Registration Statement – Securities for a Transaction   —   Form S-3   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3         Registration Statement - Securities for a           HTML    196K 
                Transaction                                                      
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML      9K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML      5K 
 4: EX-23.2     Consent of Expert or Counsel                        HTML      5K 
 5: EX-23.3     Consent of Expert or Counsel                        HTML      5K 


‘EX-5.1’   —   Opinion of Counsel re: Legality


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 5.1

 

June 28, 2021

 

AdaptHealth Corp.

220 West Germantown Pike, Suite 250

Plymouth Meeting, PA 19462

 

Re:      Form S-3 Registration Statement

 

Ladies and Gentlemen:

 

We have acted as counsel to AdaptHealth Corp., a Delaware corporation (the “Company”), in connection with the Company’s Registration Statement on Form S-3 to which this opinion is filed as an exhibit (the “Registration Statement”), filed with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Act of 1933, as amended (the “Securities Act”), for the registration of an aggregate of 27,040,088 shares of Class A common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Selling Stockholder Shares”) to be sold from time to time by certain selling stockholders of the Company.

 

We have examined copies of the Second Amended and Restated Certificate of Incorporation of the Company (the “Certificate of Incorporation”), the Amended and Restated Bylaws of the Company, the Registration Statement, the prospectus included in the Registration Statement (the “Prospectus”), relevant resolutions adopted by the Company’s Board of Directors (the “Board of Directors”), and other records and documents that we have deemed necessary for the purpose of this opinion.

 

We have also examined the specimen Common Stock, and are familiar with originals or copies, certified or otherwise identified to our satisfaction, of such other documents, corporate records, papers, statutes and authorities as we have deemed necessary to form a basis for the opinions hereinafter expressed.

 

In our examination, we have assumed the genuineness of all signatures and the conformity to original documents of all copies submitted to us. As to various questions of fact material to our opinion, we have relied on statements and certificates of officers and representatives of the Company and public officials.

 

Based on and subject to the foregoing and to the other qualifications and limitations set forth herein, we are of the opinion that the Selling Stockholder Shares are validly issued, fully paid and non-assessable.

 

The opinions expressed herein are limited to the laws of the General Corporation Law of the State of Delaware and we express no opinion with respect to the laws of any other country, state or jurisdiction.

 

The opinions expressed herein are limited to matters expressly set forth herein, and no opinion is to be implied or may be inferred beyond the matters expressly stated herein.

 

 C: 

 

 

 

The opinions expressed herein are given as of the date hereof, and we assume no obligation to update or supplement such opinions after the date hereof. The opinions expressed herein are rendered as of the date first written above and we disclaim any obligation to advise you of facts, circumstances, events or developments that hereafter may be brought to our attention and that may alter, affect or modify the opinions expressed herein. The opinions expressed herein are expressly limited to the matters set forth above and we render no opinion, whether by implication or otherwise, as to any other matters relating to the Company, the selling stockholders or the Selling Stockholder Shares.

 

We hereby consent to the filing of this opinion with the Commission as an exhibit to the Registration Statement and to the use of our name under the heading “Legal Matters” in the Registration Statement and in the related prospectus or any supplemental prospectus thereto. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

 

  Very truly yours,
   
  /s/ Willkie Farr & Gallagher LLP
   
  Willkie Farr & Gallagher LLP

 

 C: 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-3’ Filing    Date    Other Filings
Filed as of:6/29/218-K/A
Filed on:6/28/218-K/A
 List all Filings 


22 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/10/21  AdaptHealth Corp.                 10-Q        3/31/21   84:10M                                    Toppan Merrill Bridge/FA
 4/30/21  AdaptHealth Corp.                 10-K/A     12/31/20  114:17M                                    Toppan Merrill Bridge/FA
 4/30/21  AdaptHealth Corp.                 8-K:4       4/28/21   10:197K                                   Toppan Merrill/FA
 4/29/21  AdaptHealth Corp.                 8-K:1,2,9   4/23/21   11:402K                                   Toppan Merrill/FA
 4/13/21  AdaptHealth Corp.                 8-K:7,8,9   4/13/21   11:196K                                   Toppan Merrill/FA
 3/16/21  AdaptHealth Corp.                 10-K       12/31/20  113:16M                                    Toppan Merrill Bridge/FA
 3/09/21  AdaptHealth Corp.                 8-K:4       3/03/21   10:254K                                   Toppan Merrill/FA
 3/04/21  AdaptHealth Corp.                 8-K:5       3/03/21   10:193K                                   Toppan Merrill/FA
 2/02/21  AdaptHealth Corp.                 8-K:1,2,3,5 1/28/21   13:1.9M                                   Toppan Merrill/FA
 1/20/21  AdaptHealth Corp.                 DEF 14A     3/03/21    1:4.7M                                   Toppan Merrill/FA
 1/12/21  AdaptHealth Corp.                 8-K:8,9     1/05/21   12:589K                                   Toppan Merrill/FA
 1/08/21  AdaptHealth Corp.                 8-K:1,2,9   1/04/21   11:1.2M                                   Toppan Merrill/FA
12/14/20  AdaptHealth Corp.                 8-K:7,9    12/14/20   17:2.6M                                   Toppan Merrill/FA
12/07/20  AdaptHealth Corp.                 8-K:1,3,9  12/01/20   12:1.4M                                   Toppan Merrill/FA
 7/02/20  AdaptHealth Corp.                 8-K:1,2,3,5 7/01/20    6:708K                                   Toppan Merrill/FA
 6/18/20  AdaptHealth Corp.                 8-K:8,9     6/18/20    4:929K                                   Toppan Merrill/FA
 3/06/20  AdaptHealth Corp.                 10-K       12/31/19  106:14M                                    Toppan Merrill Bridge/FA
11/14/19  AdaptHealth Corp.                 8-K:1,2,4,511/07/19   25:6.7M                                   Toppan Merrill/FA
10/17/19  AdaptHealth Corp.                 8-K:1,9    10/15/19    4:303K                                   Toppan Merrill/FA
 7/12/19  AdaptHealth Corp.                 8-K:1,3,9   7/08/19    5:2.2M                                   Toppan Merrill/FA
 2/15/18  AdaptHealth Corp.                 8-A12B                 1:41K                                    Toppan Merrill/FA
 2/12/18  AdaptHealth Corp.                 S-1/A                 20:1.7M                                   Toppan Merrill-FA
Top
Filing Submission 0001104659-21-086386   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 11:58:07.1pm ET